Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes

BACKGROUND: An effective vaccine and new therapeutic methods for hepatitis C virus (HCV) are needed, and a potent HCV vaccine must induce robust and sustained cellular-mediated immunity (CMI). Research has indicated that adenoviral and vaccinia vectors may have the ability to elicit strong B and T c...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jie, Wen, Bo, Deng, Yao, Zhang, Ke, Chen, Hong, Wu, Xiaobing, Ruan, Li, Tan, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225406/
https://www.ncbi.nlm.nih.gov/pubmed/22054309
http://dx.doi.org/10.1186/1743-422X-8-506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225406/
https://www.ncbi.nlm.nih.gov/pubmed/22054309
http://dx.doi.org/10.1186/1743-422X-8-506

Ejemplares similares